Updated ASCO Guideline for first-line HER2 + gastroesophageal carcinoma:
💠 PD-L1 ≥1 (pMMR/MSS): HER2 antibody + immunotherapy + fluoropyrimidine & platinum chemo
💠PD-L1 <1 (pMMR/MSS): HER2 antibody + fluoropyrimidine & platinum chemo
Read the updated guideline: https://bit.ly/4AzBNWH
#ASCOGuidelines

ASCO Guideline Update: Therapy for Stage IV NSCLC w/ Driver Alterations

For first-line EGFR exon 20 insertions, clinicians should offer sunvozertinib monotherapy or platinum doublet chemotherapy plus amivantamab.

Read the updated guideline: https://bit.ly/46JViOM
#ASCOGuidelines